| 285 | In silico modelling of aspirin action on platelet and megakaryocyte Cyclooxygenase-1
Giaretta A., Rocca B., Di Camillo B., Toffolo GM., Patrono C. |
| 434 | Prostaglandin E2 promotes the release of angiogenic factors from platelets: role of EP3 receptor
Finetti F., Valentino S., Ziche M., Donnini S. |
| 479 | The display of pro-thrombotic phenotype of mice carrying the BDNF Val66Met human polymorphism is prevented by treatment with Resveratrol
Amadio P., Gianellini S., Tarantino E., Ieraci A., Brioschi M., Banfi C., Lee FS., Tremoli E., Barbieri SS. |
| 480 | Thromboxane pathway and venous thrombosis: ASA effects in mouse model
Tarantino E., Amadio P., Cavalca V., Porro B., Squellerio I., Tremoli E., Barbieri SS. |
| 500 | PPAR alpha-agonist treatment prevents the development of cardiac hypertrophy in a rat model of renovascular hypertension
Gelosa P., Castiglioni L., Pignieri A., Busca GA., Bena L., Locatelli G., Guerrini U., Fontana L., Riccabono P., Turolo L., Tremoli E., Sironi L. |
| 585 | Pre-analytical biases in investigating low-dose aspirin responsiveness and comparison of two different methods
Petrucci G., Rizzi A., Pagliaccia F., Pitocco D., Zaccardi F., Cavalca V., Porro B., Squellerio I., Patrono C., Rocca B. |
| 615 | Effect of Captopril treatment on platelet Tissue Factor expression in stroke-prone rats
Brambilla M., Gelosa P., Rossetti L., Castiglioni L., Canzano P., Sironi L., Tremoli E., Camera M. |
| 707 | Sex-gender and antithrombotic therapy in patients with atrial fibrillation: results from the ATA-AF study by the Italian Scientific Societies ANMCO and FADOI
Ciarambino T., Lucci D., Gonzini L., Di Pasquale G., Mathieu G., Campanini M., Vescovo G., Politi C. |
